MAPT and Alzheimer disease: Not only has the research shown that sTREM2 directly interacts with AD pathologies, but its levels in cerebrospinal fluid (CSF) were reportedly elevated in AD patients compared to controls, and it showed a correlation to total tau and phosphorylated tau but not to Aβ [16,17].